|
Name
|
Auflagedatum
|
Volumen
|
YTD-P
|
1-Y-P
|
3-Y-P
|
5-Y-P
|
|
RH&PARTNER Investment Funds - RH&P Global Life Sciences Fund
LU0115986761
USD / Acc. / Retail
|
06.09.2000
25,9 Jahre
|
65,99 |
+15,23% |
+42,47% |
+34,78% |
+18,69% |
|
ARK Genomic Revolution UCITS ETF
IE000O5M6XO1
USD / Acc. / Retail
|
12.04.2024
2,3 Jahre
|
71,16 |
+49,95% |
+79,47% |
N/A |
N/A |
|
RIM Global Bioscience
LU0120651160
EUR / Dist. / Retail
|
13.02.2001
25,5 Jahre
|
113,43 |
+15,63% |
+69,15% |
+82,56% |
+63,67% |
|
Aescap Life Sciences
NL0012343958
EUR / Acc. / Retail
|
29.03.2016
10,3 Jahre
|
144,33 |
+14,46% |
+82,72% |
+75,69% |
+25,19% |
|
ERSTE STOCK BIOTEC
AT0000746755
EUR / Acc. / Retail
|
17.04.2000
26,3 Jahre
|
286,43 |
+11,88% |
+52,57% |
+48,19% |
+34,69% |
|
Allianz Biotechnologie
DE0008481862
EUR / Dist. / Retail
|
09.01.1998
28,6 Jahre
|
287,17 |
+12,48% |
+49,62% |
+35,99% |
+25,04% |
|
JPMorgan Funds - Thematics - Genetic Therapies Fund
LU2050612402
USD / Acc. / Retail
|
24.10.2019
6,8 Jahre
|
354,68 |
+17,62% |
+56,04% |
+19,19% |
-24,24% |
|
DWS ESG Biotech
DE0009769976
EUR / Acc. / Retail
|
16.08.1999
27,0 Jahre
|
375,92 |
+9,46% |
+50,14% |
+44,36% |
+31,72% |
|
Invesco NASDAQ Biotech UCITS ETF
IE00BQ70R696
USD / Acc. / Retail
|
06.11.2014
11,7 Jahre
|
406,70 |
+18,31% |
+59,80% |
+55,37% |
+34,86% |
|
UBS (Lux) Equity Fund - Biotech (USD)
LU0069152568
USD / Acc. / Retail
|
15.10.1996
29,8 Jahre
|
450,23 |
+19,91% |
+62,56% |
+47,33% |
+28,75% |